Cubist Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall Of One Lot Of CUBICIN (Daptomycin For Injection) 500 Mg In 10 Ml Single Use Vials Due To Presence Of Particulate Matter

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer.

Help employers find you! Check out all the jobs and post your resume.